Topics

Nalmefene in alcohol-dependent patients with a high drinking risk: a randomized controlled trial.

08:00 EDT 12th July 2019 | BioPortfolio

Summary of "Nalmefene in alcohol-dependent patients with a high drinking risk: a randomized controlled trial."

Reducing alcohol consumption is one treatment approach for alcohol-dependent patients. This study compared nalmefene 20 mg and 10 mg with placebo, combined with psychosocial support, in alcohol-dependent Japanese patients with a high or very high drinking risk level (DRL).

Affiliation

Journal Details

This article was published in the following journal.

Name: Psychiatry and clinical neurosciences
ISSN: 1440-1819
Pages:

Links

DeepDyve research library

PubMed Articles [51577 Associated PubMed Articles listed on BioPortfolio]

Drinking Levels and Profiles of Alcohol Addicted Rats Predict Response to Nalmefene.

Pharmacotherapeutic options supporting the treatment of alcohol dependence are recommended and available but underutilized, partly due to questions about efficacy. Nalmefene, a μ-opioid receptor anta...

Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study.

The aims were to identify patients with rheumatoid arthritis (RA) who had stopped drinking alcohol and compare them with patients drinking alcohol, and to explore reasons for stopping drinking alcohol...

Age, Race, and At-Risk Drinking in an HIV-infected U.S. Military Cohort.

There is a high prevalence of at-risk drinking in the U.S. military. Among HIV-infected individuals, alcohol abuse confers additional risk for adverse health outcomes. In the military, however, the ch...

Adolescent Binge Drinking.

Binge drinking, commonly defined as consuming five or more standard drinks per occasion for men and four or more drinks for women, typically begins in adolescence. Adolescents, although they may drink...

Alcohol Use Disorder and Alcohol Withdrawal Syndrome in Vietnamese Hospitalized Patients.

To identify the extent to which patients admitted to a general hospital in Vietnam meet the criteria for risky alcohol drinking, alcohol use disorder (AUD), and alcohol withdrawal syndrome (AWS), desc...

Clinical Trials [13501 Associated Clinical Trials listed on BioPortfolio]

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Nalmefene is the first drug to obtain Marketing Authorisation in France for reduction of alcohol consumption. It appears to be significantly more effective in the group of heavy drinkers, ...

Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity

The aim of this study is to use functional Magnetic Resonance Imaging (fMRI) to measure neural reactivity to alcohol-related and emotional cues in alcohol dependent subjects following a si...

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.

Unhealthy Alcohol Drinking and Anesthetic Requirement in Women

Unhealthy alcohol drinking is negatively influencing health of people and costing a large number of annual finance via "secondhand" effects. Additionally, unhealthy alcohol use covers a sp...

Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation

Background: Drugs like nalmefene interfere with opioid receptors. This might reduce drinking. The gene OPRM1 determines opioid receptor functions. Researchers want to see if nalmefene aff...

Medical and Biotech [MESH] Definitions

Behaviors associated with the ingesting of alcoholic beverages, including social drinking.

Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.

A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.

Alcohol consumption among college students.

Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.

Quick Search


DeepDyve research library

Searches Linking to this Article